Ticker
LXRXCompany Name
LEXICON PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 50.36M | 1.45 | $ 34.84M |
3/31/2025 | $ 62.89M | 0.57 | $ 110.69M |
12/31/2024 | $ 66.66M | 1.47 | $ 45.25M |
9/30/2024 | $ 34.55M | 0.96 | $ 36.05M |
6/30/2024 | $ 35.62M | 1.28 | $ 27.88M |
3/31/2024 | $ 96.49M | 4.12 | $ 23.4M |
12/31/2023 | $ 22.46M | 0.71 | $ 31.55M |
9/30/2023 | $ 21.12M | 0.65 | $ 32.26M |
6/30/2023 | $ 102.27M | 3.92 | $ 26.11M |
3/31/2023 | $ 26M | 1.28 | $ 20.37M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for LEXICON PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 52.25M ] / LiabilitesC [ $ 78.92M ]
(=) Cash Ratio [ 0.66 ]
Minimum
Mar 31, 2025
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |